What is the equity of Pro Medicus this year?
Pro Medicus has equity of 138.78 M AUD this year.
In 2024, Pro Medicus's equity was 138.78 M AUD, a 36.41% increase from the 101.73 M AUD equity in the previous year.
Pro Medicus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Pro Medicus's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Pro Medicus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Pro Medicus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Pro Medicus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Pro Medicus has equity of 138.78 M AUD this year.
The equity of Pro Medicus has increased/decreased by 36.41% increased compared to the previous year.
A high equity is advantageous for investors of Pro Medicus as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Pro Medicus, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Pro Medicus can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Pro Medicus can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Pro Medicus include profits, dividend payments, capital increases, and acquisitions.
The equity of Pro Medicus is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Pro Medicus can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Pro Medicus paid a dividend of 0.43 AUD . This corresponds to a dividend yield of about 0.32 %. For the coming 12 months, Pro Medicus is expected to pay a dividend of 0.48 AUD.
The current dividend yield of Pro Medicus is 0.32 %.
Pro Medicus pays a quarterly dividend. This is distributed in the months of October, April, October, March.
Pro Medicus paid dividends every year for the past 19 years.
For the upcoming 12 months, dividends amounting to 0.48 AUD are expected. This corresponds to a dividend yield of 0.36 %.
Pro Medicus is assigned to the 'Health' sector.
To receive the latest dividend of Pro Medicus from 3/22/2024 amounting to 0.257 AUD, you needed to have the stock in your portfolio before the ex-date on 2/29/2024.
The last dividend was paid out on 3/22/2024.
In the year 2023, Pro Medicus distributed 0.314 AUD as dividends.
The dividends of Pro Medicus are distributed in AUD.
Our stock analysis for Pro Medicus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pro Medicus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.